December 08, 2004
Arimidex Better Than Tamoxifen in Preventing Breast Cancer Recurrence
The data shows that in postmenopausal women with hormone sensitive, early breast cancer, Arimidex reduces the risk of breast cancer returning by an additional 26 per cent over and above the 50 per cent reduction in risk already offered by Tamoxifen, and it has fewer side effects.
